as 07-26-2024 4:00pm EST
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
Upcoming Earnings Alert:
Get ready for potential market movements as Glaukos Corporation GKOS prepares to release earnings report on 31 Jul 2024.
Founded: | 1998 | Country: | United States |
Employees: | N/A | City: | ALISO VIEJO |
Market Cap: | 6.7B | IPO Year: | 2015 |
Target Price: | $119.18 | AVG Volume (30 days): | 584.6K |
Analyst Decision: | Buy | Number of Analysts: | 11 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -2.88 | EPS Growth: | N/A |
52 Week Low/High: | $59.22 - $126.96 | Next Earning Date: | 07-31-2024 |
Revenue: | $326,434,000 | Revenue Growth: | 12.92% |
Revenue Growth (this year): | 17.56% | Revenue Growth (next year): | 23.70% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Gilliam Joseph E | GKOS | PRESIDENT & COO | Jul 5 '24 | Sell | $121.39 | 2,250 | $273,127.50 | 101,845 | SEC Form 4 |
Gilliam Joseph E | GKOS | PRESIDENT & COO | Jun 3 '24 | Sell | $114.73 | 190 | $21,798.70 | 101,845 | SEC Form 4 |
Gilliam Joseph E | GKOS | PRESIDENT & COO | Jun 3 '24 | Sell | $114.22 | 936 | $106,909.92 | 102,035 | SEC Form 4 |
Gilliam Joseph E | GKOS | PRESIDENT & COO | Jun 3 '24 | Sell | $112.84 | 1,374 | $155,042.16 | 102,971 | SEC Form 4 |
Kliman Gilbert H | GKOS | Director | May 30 '24 | Sell | $112.00 | 5,000 | $560,000.00 | 30,620 | SEC Form 4 |
Stapley Marc | GKOS | Director | May 15 '24 | Sell | $113.68 | 2,000 | $227,360.00 | 32,360 | SEC Form 4 |
Stapley Marc | GKOS | Director | May 15 '24 | Sell | $112.91 | 2,200 | $248,402.00 | 34,360 | SEC Form 4 |
Stapley Marc | GKOS | Director | May 15 '24 | Sell | $111.82 | 2,050 | $229,231.00 | 36,560 | SEC Form 4 |
Gilliam Joseph E | GKOS | PRESIDENT & COO | May 10 '24 | Sell | $110.56 | 2,395 | $264,791.20 | 101,845 | SEC Form 4 |
Thurman Alex R. | GKOS | SVP & CHIEF FINANCIAL OFFICER | May 10 '24 | Sell | $110.43 | 316 | $34,895.88 | 51,684 | SEC Form 4 |
Thurman Alex R. | GKOS | SVP & CHIEF FINANCIAL OFFICER | May 10 '24 | Sell | $111.22 | 37 | $4,115.14 | 51,647 | SEC Form 4 |
Thurman Alex R. | GKOS | SVP & CHIEF FINANCIAL OFFICER | May 6 '24 | Sell | $110.26 | 90 | $9,923.40 | 52,000 | SEC Form 4 |
Gilliam Joseph E | GKOS | PRESIDENT & COO | May 6 '24 | Sell | $110.36 | 105 | $11,587.80 | 101,845 | SEC Form 4 |
Gilliam Joseph E | GKOS | PRESIDENT & COO | May 2 '24 | Sell | $104.43 | 645 | $67,357.35 | 103,259 | SEC Form 4 |
Gilliam Joseph E | GKOS | PRESIDENT & COO | May 2 '24 | Sell | $105.31 | 672 | $70,768.32 | 102,587 | SEC Form 4 |
Gilliam Joseph E | GKOS | PRESIDENT & COO | May 2 '24 | Sell | $106.39 | 577 | $61,387.03 | 102,010 | SEC Form 4 |
Gilliam Joseph E | GKOS | PRESIDENT & COO | May 2 '24 | Sell | $107.58 | 165 | $17,750.70 | 101,845 | SEC Form 4 |
Thurman Alex R. | GKOS | SVP & CHIEF FINANCIAL OFFICER | May 2 '24 | Sell | $105.25 | 335 | $35,258.75 | 52,197 | SEC Form 4 |
Thurman Alex R. | GKOS | SVP & CHIEF FINANCIAL OFFICER | May 2 '24 | Sell | $106.58 | 65 | $6,927.70 | 52,132 | SEC Form 4 |
Thurman Alex R. | GKOS | SVP & CHIEF FINANCIAL OFFICER | May 2 '24 | Sell | $107.77 | 42 | $4,526.34 | 52,090 | SEC Form 4 |
Gilliam Joseph E | GKOS | PRESIDENT & COO | Apr 8 '24 | Sell | $102.13 | 86 | $8,783.18 | 101,845 | SEC Form 4 |
Gilliam Joseph E | GKOS | PRESIDENT & COO | Apr 8 '24 | Sell | $101.28 | 8,191 | $829,584.48 | 101,931 | SEC Form 4 |
Gilliam Joseph E | GKOS | PRESIDENT & COO | Apr 8 '24 | Sell | $100.52 | 41,068 | $4,128,155.36 | 110,122 | SEC Form 4 |
Gilliam Joseph E | GKOS | PRESIDENT & COO | Apr 8 '24 | Sell | $99.64 | 10,456 | $1,041,835.84 | 151,190 | SEC Form 4 |
Thurman Alex R. | GKOS | SVP & CHIEF FINANCIAL OFFICER | Apr 5 '24 | Sell | $95.55 | 18 | $1,719.90 | 54,148 | SEC Form 4 |
GKOS Breaking Stock News: Dive into GKOS Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Zacks
2 days ago
Argus Research
3 days ago
Zacks
4 days ago
Argus Research
10 days ago
Zacks
11 days ago
MT Newswires
12 days ago
Zacks
14 days ago
The information presented on this page, "GKOS Glaukos Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.